BUY Metropolis Healthcare Limited — Emkay Global
byEmkay GlobalHorizon: NA (inferred 1 year)28 Aug 2026via ET Now (Live)
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Long-term trend bullish — 200-day average rising over the past quarter
Technicals · trend·21 Oct · yesterday
Metropolis Healthcare’s Credit Profile Gains Momentum, Crisil Maintains ‘AA-’ Rating And Lifts Outlook
NewsGoogle News·23 Sept · 4w ago
2 other SEBI-registered advisors have active long-term BUY calls on this stock
Advisor consensus · same horizon·6 Aug · 3mo ago
Nothing found in this tip’s window yet.
1 other SEBI-registered advisor has an active long-term SELL call on this stock
Advisor consensus · same horizon·6 Oct · 2w ago
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Metropolis Healthcare
- BUY — Kunal Bothra6 Oct 2026 · ~2 weeks · target ₹600 · SL hit
- SELL — Citigroup6 Oct 2026 · ~1 year · target ₹465 · Active
- BUY — Aastha Jain, Hem Securities6 Oct 2026 · ~2 weeks · target ₹580 · SL hit
- BUY — Rakesh Bansal24 Sept 2026 · ~2 weeks · target ₹611 · SL hit
- BUY — Kunal Hasmukhlal Shah10 Sept 2026 · Same day · target ₹635 · Expired
More from Emkay Global
- BUY Piramal Finance21 Oct 2026 · ~1 year · target ₹2,100 · Active
- BUY Urban Company19 Oct 2026 · ~1 year · target ₹200 · Active
- BUY ICICI Bank19 Oct 2026 · ~1 year · target ₹1,785 · Active
- BUY Ujjivan Small Finance Bank19 Oct 2026 · ~1 year · target ₹90 · Active
- BUY UltraTech Cement19 Oct 2026 · ~1 year · target ₹13,200 · Active

